IDEAS home Printed from https://ideas.repec.org/a/spr/stabio/v8y2016i1d10.1007_s12561-015-9139-3.html
   My bibliography  Save this article

A Two-Stage Adaptive Targeted Clinical Trial Design for Biomarker Performance-Based Sample Size Re-Estimation

Author

Listed:
  • Zhong Gao

    (University of Maryland, Baltimore County
    U.S. Food and Drug Administration)

  • Anindya Roy

    (University of Maryland, Baltimore County)

  • Ming Tan

    (Georgetown University)

Abstract

Biomarker-directed targeted clinical trial is aimed at developing pharmaceutical agents for a targeted patient subpopulation sharing a specific disease etiology. Biomarker plays a key role in patient enrichment for targeted trials. Biomarker performance substantially impacts heterogeneity of a targeted study population and consequently trial efficiency, statistical power, information accumulation, and early stopping decision-making (Simon and Maitournam in Clinical Cancer Res 10:6759-6763, 2004; Maitournam and Simon in Stat Med 24:329-339, 2005; Gao et al. in Contemp Clin Trials 42:119-131, 2015). Hence, accurate assessment of biomarker performance is crucial to sample size calculation in planning of targeted trials. However, prior knowledge of biomarker performance is often limited at the planning stage due to inadequacy of biomarker validation, differences between study populations in demographic characteristics and trial settings, etc. Under this circumstance, adaptive design would be useful in updating biomarker performance and re-estimating sample sizes when a targeted trial is ongoing. In this paper, we propose a two-stage adaptive design that provides flexibility in biomarker performance-based sample size adaption for targeted trials. The design can facilitate a targeted trial to achieve planned statistical power by re-assessment of actual biomarker performance and subsequent sample size adaption while preserving desired type-1 error.

Suggested Citation

  • Zhong Gao & Anindya Roy & Ming Tan, 2016. "A Two-Stage Adaptive Targeted Clinical Trial Design for Biomarker Performance-Based Sample Size Re-Estimation," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 8(1), pages 66-76, June.
    • Handle: RePEc:spr:stabio:v:8:y:2016:i:1:d:10.1007_s12561-015-9139-3
    DOI: 10.1007/s12561-015-9139-3
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s12561-015-9139-3
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s12561-015-9139-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Xiaoping Xiong & Ming Tan & James Boyett, 2003. "Sequential Conditional Probability Ratio Tests for Normalized Test Statistic on Information Time," Biometrics, The International Biometric Society, vol. 59(3), pages 624-631, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Liansheng Tang & Ming Tan & Xiao-Hua Zhou, 2011. "A sequential conditional probability ratio test procedure for comparing diagnostic tests," Journal of Applied Statistics, Taylor & Francis Journals, vol. 38(8), pages 1623-1632, July.
    2. Yuan, Ao & Zheng, Yanxun & Huang, Peng & Tan, Ming T., 2016. "A nonparametric test for the evaluation of group sequential clinical trials with covariate information," Journal of Multivariate Analysis, Elsevier, vol. 152(C), pages 82-99.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:stabio:v:8:y:2016:i:1:d:10.1007_s12561-015-9139-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.